Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
To better accelerate your GLP-1 new drug research and development, GenScript is now offering GLP-1 Receptor Agonist Services
Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)
Additionally, waiting more than 30 minutes to eat after taking the medication may increase the absorption of oral semaglutide
Improvements in energy, fitness, sleep quality, and how you feel in your body are important too
US$ 25.33
US$ 23.28
US$ 29.50
US$ 23.41
